ABCG2 and atherosclerosis: Accordingly, this paper will summarize recent developments in an emerging field where PPAR medicines, capable of modulating ABC transporter genes at the transcriptional level, may prove useful when such modulation provides novel therapeutic options for treating cancer and atherosclerosis.